SCRI Tenessee Oncology Nashville — Nashville, Tennessee

SCRI Tenessee Oncology Nashville is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

SCRI Tenessee Oncology Nashville has participated in 1 clinical trials.

Therapeutic areas: Cancer of the Breast, Breast Cancer, Advanced Breast Cancer.

Sponsors: Innocrin Pharmaceutical.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for SCRI Tenessee Oncology Nashville?

SCRI Tenessee Oncology Nashville has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has SCRI Tenessee Oncology Nashville conducted?

SCRI Tenessee Oncology Nashville has 1 clinical trials on record. Their work covers Cancer of the Breast, Breast Cancer, Advanced Breast Cancer.

Is SCRI Tenessee Oncology Nashville accredited by Crixeo Health?

SCRI Tenessee Oncology Nashville has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about SCRI Tenessee Oncology Nashville?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.